Clinical trials

  • E2814 for Dominantly Inherited Alzheimer's disease
  • ISATUXIMAB for Multiple myeloma|Relapsed or refractory multiple myeloma (RRMM)
  • REZVILUTAMIDE for Metastatic hormone-sensitive prostate cancer
  • ZOLEDRONIC ACID MONOHYDRATE for Knee osteoarthritis | Osteoarthritis of the knee
  • BELANTAMAB MAFODOTIN for Multiple myeloma | Relapsed or refractory multiple myeloma
  • Myrrh; Coffee charcoal; Dry extract from chamomile flower (4-6:1) for Irritable bowel syndrome with diarrhoea (IBS-D) | Mixed-type irritable bowel syndrome (IBS-M)
  • ISATUXIMAB for Multiple myeloma | Relapsed or refractory multiple myeloma
  • BEXICASERIN HYDROCHLORIDE for Developmental and Epileptic Encephalopathies
  • RITUXIMAB for Pemphigus vulgaris | Pemphigus foliaceus
  • SARACATINIB for Fibrodysplasia ossificans progressiva
  • VRDN-003 for Thyroid eye disease
  • RITUXIMAB for Mucous membrane pemphigoid